{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:38:22Z","timestamp":1760621902344,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001721","name":"Rijksuniversiteit Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.rmed.2020.106064","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T20:37:13Z","timestamp":1593808633000},"page":"106064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Long-acting dual bronchodilator therapy (indacaterol\/glycopyrronium) versus nebulized short-acting dual bronchodilator (salbutamol\/ipratropium) in chronic obstructive pulmonary disease: A double-blind, randomized, placebo-controlled trial"],"prefix":"10.1016","volume":"171","author":[{"given":"Wouter H.","family":"van Geffen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orestes A.","family":"Carpaij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lotte F.","family":"Westbroek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianne","family":"Seigers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Niemeijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith M.","family":"Vonk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huib A.M.","family":"Kerstjens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2018","series-title":"Initiative for Chronic Obstructive: Globat Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease Update 2018 Report","author":"Global","key":"10.1016\/j.rmed.2020.106064_bib1"},{"year":"2005","series-title":"Device Selection and Outcomes of Aerosol Therapy: Evidence-Based Guidelines: American College of Chest Physicians\/American College of Asthma, Allergy, and Immunology","author":"Dolovich","key":"10.1016\/j.rmed.2020.106064_bib2"},{"issue":"10","key":"10.1016\/j.rmed.2020.106064_bib3","article-title":"Long\u2010acting beta2\u2010agonists for chronic obstructive pulmonary disease","volume":"15","author":"Kew","year":"2013","journal-title":"Cochrane Libr."},{"issue":"6","key":"10.1016\/j.rmed.2020.106064_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2013.02.008","article-title":"Chronic treatment with indacaterol and airway response to salbutamol in stable COPD","volume":"107","author":"Cazzola","year":"2013","journal-title":"Respir. Med."},{"issue":"18","key":"10.1016\/j.rmed.2020.106064_bib5","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1713901","article-title":"Once-daily single-inhaler triple versus dual therapy in patients with COPD","volume":"378","author":"Lipson","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.rmed.2020.106064_bib6","doi-asserted-by":"crossref","DOI":"10.3109\/15412555.2011.630047","article-title":"The role of nebulized therapy in the management of COPD: evidence and recommendations","volume":"9","author":"Dhand","year":"2012","journal-title":"COPD J."},{"issue":"2","key":"10.1016\/j.rmed.2020.106064_bib7","article-title":"Practical problems with aerosol therapy in COPD","volume":"51","author":"Rau","year":"2006","journal-title":"Respir. Care"},{"issue":"2","key":"10.1016\/j.rmed.2020.106064_bib8","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.05.00034805","article-title":"ATS\/ERS task force: ATS\/ERS standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.rmed.2020.106064_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur. Respir. J."},{"issue":"A4271","key":"10.1016\/j.rmed.2020.106064_bib10","article-title":"Dual bronchodilation with once-daily Qva149 significantly Improves lung function versus single bronchodilators and salmeterol\/fluticasone","volume":"187","author":"Ferguson","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.rmed.2020.106064_bib11","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00200212","article-title":"Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study","volume":"42","author":"Bateman","year":"2013","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.rmed.2020.106064_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(18)30431-4","article-title":"Surgical and endoscopic interventions that reduce lung volume for emphysema: a systemic review and meta-analysis","volume":"7","author":"van Geffen","year":"2019","journal-title":"Lancet Respir. Med."},{"issue":"8","key":"10.1016\/j.rmed.2020.106064_bib13","article-title":"Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD","volume":"2016","author":"van Geffen","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"12","key":"10.1016\/j.rmed.2020.106064_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(15)00459-2","article-title":"Hyperinflation in COPD exacerbations","volume":"3","author":"van Geffen","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2020.106064_bib15","article-title":"Static and dynamic hyperinflation during severe acute exacerbations of chronic obstructive pulmonary disease","volume":"13","author":"Geffen","year":"2018","journal-title":"Int. J. COPD"},{"issue":"1","key":"10.1016\/j.rmed.2020.106064_bib16","article-title":"Evaluation of patient-reported outcomes and quality of life with the I-neb AAD system in patients with chronic obstructive pulmonary disease","volume":"23","author":"Goodman","year":"2010","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"issue":"11","key":"10.1016\/j.rmed.2020.106064_bib17","article-title":"Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING)","volume":"28","author":"Marin","year":"2016","journal-title":"Int. J. COPD"},{"issue":"5","key":"10.1016\/j.rmed.2020.106064_bib18","article-title":"Onset of action of indacaterol in patients with COPD: comparison with salbutamol and salmeterol-fluticasone","volume":"7","author":"Balint","year":"2010","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.rmed.2020.106064_bib19","article-title":"Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON study","volume":"8","author":"Dahl","year":"2013","journal-title":"Int. J. COPD"},{"issue":"23","key":"10.1016\/j.rmed.2020.106064_bib20","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1516385","article-title":"Indacaterol-glycopyrronium versus salmeterol-fluticasone for COPD","volume":"374","author":"Wedzicha","year":"2016","journal-title":"N. Engl. J. Med."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611120302043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611120302043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:06:49Z","timestamp":1760616409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611120302043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":20,"alternative-id":["S0954611120302043"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2020.106064","relation":{},"ISSN":["0954-6111"],"issn-type":[{"type":"print","value":"0954-6111"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-acting dual bronchodilator therapy (indacaterol\/glycopyrronium) versus nebulized short-acting dual bronchodilator (salbutamol\/ipratropium) in chronic obstructive pulmonary disease: A double-blind, randomized, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2020.106064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106064"}}